Approval · Notice of Compliance 3622 · 2003
MARINOL: Notice of Compliance 3622
Issued January 3, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3622
- Date
- January 3, 2003
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiemetic
Products in this notice
Medicinal ingredients
- DRONABINOL 2.5 MG per CAP
- DRONABINOL 5 MG per CAP
- DRONABINOL 10 MG per CAP